CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-23 | Rasdal Andrew P President, CEO & Exec Chairman | Grant or award · Stock Option | +52,865 | 52,865 | ||
| 2020-06-23 | Rasdal Andrew P President, CEO & Exec Chairman | Grant or award · Stock Option (Right to Buy) | +165,135 | 165,135 | ||
| 2019-08-06 | Rasdal Andrew P Exec Chairman of the Board | Purchase | +12,500 | $4.00 | $50K | 77,892 |
| 2019-08-06 | Rasdal Andrew P Exec Chairman of the Board | Purchase · Warrants (Right to Buy) | +9,375 | 9,375 | ||
| 2019-01-02 | Rasdal Andrew P Exec Chairman of the Board | Grant or award | +86,957 | 653,905 | ||
| 2018-08-23 | Rasdal Andrew P CEO | Grant or award | +109,890 | $1.82 | $200K | 566,948 |
| 2018-04-30 | Rasdal Andrew P President & CEO | Grant or award | +2,987 | $3.27 | $10K | 457,058 |
| 2018-01-02 | Rasdal Andrew P President & CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2017-10-31 | Rasdal Andrew P President & CEO | Grant or award | +808 | $7.17 | $6K | 454,071 |
| 2017-04-30 | Rasdal Andrew P President & CEO | Grant or award | +2,768 | $9.03 | $25K | 453,263 |
| 2016-11-09 | Rasdal Andrew P President & CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 |
Page 1 of 1 · 11 trades